NYMOX PHARMACEUTICAL CORP

NYMXF · In Vitro and in Vivo Diagnostic Substances

Save to watchlist Sign in to save

Latest available SEC filing: 20-F/A ·

Latest disclosures

All company filings

Institutional holders by security

Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.

  • NYMXF · P73398102 - Common Stock
Company details and SEC sources

CIK 0001018735 · SEC filing index. Filing dates describe disclosures, not live market data.

Listed symbols
NYMXF
At a glance Names, identifiers, and filing context for this profile. 2 identity fields
SEC industry group
In Vitro and in Vivo Diagnostic Substances (Office of Life Sciences)
Business address
9900 Cavendish Blvd., Suite 306, St. Laurent, Quebec Canada, Quebec, Canada, H4M 2V2
EDGAR profile Static EDGAR fields kept behind disclosure so the main profile stays readable. 1 profile field available
Fiscal year end
31 December
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .